CSIMarket Company Name, Ticker, Customers, else..
 
Scilex Holding Company  (NASDAQ: SCLX)
 
Price: $5.4150 $0.13 2.557%
Day's High: $5.71999979019165 Week Perf: -1.46 %
Day's Low: $ 5.31 30 Day Perf: -21.97 %
Volume (M): 40,414 52 Wk High: $ 34.27
Volume (M$): $ 0 52 Wk Avg: $11.41
Open: $5.41 52 Wk Low: $4.20



 Market Capitalization (Millions $) 37
 Shares Outstanding (Millions) 7
 Employees 34
 Revenues (TTM) (Millions $) 32
 Net Income (TTM) (Millions $) -449
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 35

Business Description


Scilex Holding Company is a pharmaceutical company that focuses on developing and commercializing innovative pain management products. The company is dedicated to providing patients with effective and safe treatments for various types of pain conditions. Scilex Holding Company is committed to leveraging technology and scientific expertise to deliver advanced therapeutic options to improve the quality of life for individuals suffering from pain.


   Company Address: 960 San Antonio Road Palo Alto 94303 CA
   Company Phone Number: 516-4310   Stock Exchange / Ticker: NASDAQ SCLX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Partnership

Scilex Holding Company Expands Its Footprint in the Non-Opioid Pain Management Market with Strategic Partnerships and...

Published Wed, Sep 24 2025 2:55 PM UTC

Scilex Holding Company (Nasdaq: SCLX), known for its focus on non-opioid pain management solutions, has been actively pursuing strategic partnerships and initiatives that signal its commitment to enhancing operational capabilities and market reach. Recently, the company announced a series of collaborations and agreements intended to bolster its product distribution and explo...
Shares

Scilex Holding Company Implements 1-for-35 Reverse Stock Split Amid Legal and Financial Developments,

Published Fri, Apr 11 2025 1:00 PM UTC

Scilex Holding Company Executes 1-for-35 Reverse Stock Split Amid Recent Legal DevelopmentsPALO ALTO, Calif. April 11, 2025 Scilex Holding Company (Nasdaq: SCLX), an innovative revenue-generating firm focusing on the acquisition, development, and commercialization of non-opioid pain management products, has announced a significant restructuring of its shares. Effective Apr...
Shares

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025

Published Fri, Jan 31 2025 2:00 PM UTC

Scilex Holding Company: Navigating Lockup Extensions and Compliance Triumphs Amid Strategic ExpansionPALO ALTO, Calif. Jan. 31, 2025 In a pivotal moment for Scilex Holding Company (Nasdaq: SCLX), the U.S. Bankruptcy Court for the Southern District of Texas has granted an extension on the lock-up period for shares of common stock previously distributed by Sorrento Therapeu...
Shares

Scilex Holding Company Regains Nasdaq Compliance: A Turning Point for Shareholders Amidst Capital Infusion Efforts

Published Tue, Jan 21 2025 4:49 PM UTC

In a recent press release, Scilex Holding Company (Nasdaq: SCLX) announced that it has successfully regained compliance with The Nasdaq Stock Market LLC s Listing Rule 5250(c)(1). This development comes in the wake of the company submitting its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, a document that had been overdue and pivotal for maintaining...
Management Announcement

Scilex Navigates Financial Hardship While Unveiling ZTlido Study - A Critical Juncture in Pain Management Innovations,

Published Mon, Jan 13 2025 2:00 PM UTC

Scilex Holding Company Faces Financial Strain Amid New Study on ZTlido vs. Lidocaine PatchScilex Holding Company Announces Pain Medicine Study and Financial Challenges Palo Alto, CA – January 13, 2025 – Scilex Holding Company (Nasdaq: SCLX), a company dedicated to the development and commercialization of non-opioid pain management therapies, finds itself at a crucial ju...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.18
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0
Working Capital Ratio 0.07
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -51.91 $
Revenues (TTM) 4.59 $
Cash Flow (TTM) -
Cash 0.08 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 929,647
Net Income per Employee (TTM) -13,194,176
Receivable Turnover Ratio (TTM) 1.93
Inventory Turnover Ratio (TTM) 3.86
Asset Turnover Ratio (TTM) 0.11

Profitability Ratios Current
Gross Margin (MRQ) 51.88 %
Operating Margin (MRQ) -385.02 %
Net Margin (MRQ) -1504.66 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Scilex Holding's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.